Approval · Notice of Compliance 20165 · 2017
PERGOVERIS: Notice of Compliance 20165
Issued December 13, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20165
- Date
- December 13, 2017
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERGOVERIS | 02470640 | Marketed |
| PERGOVERIS | 02470659 | Marketed |
| PERGOVERIS | 02470667 | Marketed |
Medicinal ingredients
- FOLLITROPIN ALFA 300 UNIT per DOSE
- LUTROPIN ALFA 150 UNIT per DOSE
- FOLLITROPIN ALFA 450 UNIT per DOSE
- LUTROPIN ALFA 225 UNIT per DOSE
- FOLLITROPIN ALFA 900 UNIT per DOSE
- LUTROPIN ALFA 450 UNIT per DOSE